Olympus Corporation (OCPNF)
OTCMKTS
· Delayed Price · Currency is USD
12.92
+0.26 (2.08%)
At close: May 20, 2025
Olympus Revenue
In the fiscal year ending March 31, 2025, Olympus had annual revenue of 997.33B JPY with 6.53% growth. Olympus had revenue of 272.11B in the quarter ending March 31, 2025, with 4.46% growth.
Revenue
997.33B JPY
Revenue Growth
+6.53%
P/S Ratio
2.28
Revenue / Employee
34.58M JPY
Employees
28,838
Market Cap
15.18B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 997.33B | 61.12B | 6.53% |
Mar 31, 2024 | 936.21B | 54.29B | 6.16% |
Mar 31, 2023 | 881.92B | 13.06B | 1.50% |
Mar 31, 2022 | 868.87B | 138.32B | 18.93% |
Mar 31, 2021 | 730.54B | -66.87B | -8.39% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Olympus News
- 25 days ago - Olympus Corporation (OLYMY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Olympus Corporation 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 4 months ago - Olympus Corporation (OLYMY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Olympus Launches Global Search for New CEO Amid Leadership Transition - CEOWORLD magazine
- 7 months ago - Olympus Corporation (OLYMY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Olympus shares drop over 5% after CEO resigns over drug allegation - CNBC
- 7 months ago - Olympus CEO steps down amid illegal drug purchase allegations; endoscope manufacturer's shares drop 7% - Invezz
- 10 months ago - Olympus Corporation (OLYMY) Q1 2025 Earnings Call Transcript - Seeking Alpha